As the leading modifiable risk factor for global cardiovascular disease, hypertension management is among the most important tasks for clinicians worldwide [1]. Unfortunately, despite significant advances in our understanding of improved treatment thresholds, identification of secondary causes, and development of new pharmacotherapies, control of hypertension has stagnated and even reversed in the last 10 years, highlighting the need for novel therapeutic approaches [2, 3].
